InsideArbitrage Event Driven Monitor – January 4, 2024

Merger Arbitrage

1. IMGN: The shareholder meeting to vote on the acquisition of ImmunoGen (IMGN) by AbbVie (ABBV) for $7.29 billion or $31.26 per share in cash is scheduled for January 31, 2023.
2. FGH: The business combination between FG Group Holdings (FGH) and FG Financial Group (FGF) for $38.87 million in an all-stock deal.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.